Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), the developer of novel immunotherapies for the treatment of cancer and infectious disease, has reported its financial results for the year ended 30 April 2022 and issued a business update on progress achieved post-period.
In the statement, professor Lindy Durrant, chief executive officer of Scancell, commented: "It has been a year of strong operational and clinical progress for Scancell with three vaccine candidates now in the clinic and the antibody platforms gathering momentum with expanded internal research and external validation.
Iofina PLC (AIM:IOF, OTC:IOFNF) news that the starting gun has been fired on its next growth phase, with new brine supply agreements for its latest iodine plant expansion concluded, paving the way for construction to begin should "be well received" according to analysts at finnCap.
The 'house' broker's analysts said: "This will be Iofina’s sixth operating iodine plant; with an anticipated construction time of just six months and an expected capacity of 100-150 MT, it will rapidly and materially boost Iofina’s iodine production and deliver a fast payback on investment."
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) 'house' broker finnCap says news that the company expects to restart production at its UK manufacturing site on 14 November is "welcome news".
However, the City broker's analysts noted that the circa 7-week voluntary shut-down falls in the peak production months in preparation for dosing patients ahead of the pollen season in the spring.
Greatland Gold PLC (AIM:GGP, OTC:GRLGF) reiterated work so far on the Havieron gold and copper deposit was just the "tip of the iceberg" for the project.
A pre-feasibility study published earlier this year covered just a fraction of the initial resource, Greatland said, and justified the fast start approach to early cashflow generation and reinvesting back into Havieron development and infrastructure.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) is set to resume operations at its Freeman facility in Worthing, UK from November 14.
The AIM-listed biotech company voluntarily paused production following an internal review of its current operating processes as part of a previously communicated ongoing programme to improve the robustness of and build capacity across its manufacturing facilities.
Condor Gold PLC (AIM:CNR, TSX:COG, OTC:CNDGF) said it does not expect the recent sanctions imposed by the US on Nicaragua to have an impact on its operation in the country.
President Joe Biden introduced measures on Monday targeting Nicaragua’s mining, gold and other sectors, all of which are significant earners for the country.
Iofina PLC (AIM:IOF, OTC:IOFNF) said it has executed all agreements with a new brine supply partner to construct its latest IOsorb iodine plant, IO#9, in Western Oklahoma.
Construction is expected to take six months, it added, and will take the number of its iodine production plants in operation to six.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) noted that a newly updated corporate presentation has been added to the company’s website, adding details about the planned Hickory-1 exploration well set to be drilled in the first half of 2023.
Ondine Biomedical Inc (AIM:OBI) chief financial officer Vipul Shah increased his shareholding in the company, acquiring 25,000 shares at a price of 25p, to take his interest to 0.026%.
Tirupati Graphite PLC (LSE:TGR, OTCQX:TGRHF) said it remains on track to increase production and build further capacity towards a target of 30,000 tpa in the near term, and to 84,000 tpa through a modular, step-by-step approach in the following years (read here).